RO 244383
Latest Information Update: 17 Jul 2000
At a glance
- Originator Roche
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors; DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 17 Jul 2000 Discontinued-Preclinical for Bacterial infections in USA (Unknown route)